CCH NetNews™

(July 20, 2010)

Food and Drug Law

Order or Get More Information in the CCH®s Online Store

 New and Improved

Continuing to to provide you with the most up-to-date, accurate information, CCH introduces new enhancements for the Food, Drug & Cosmetic Reporter and the Medical Devices Reporter. These include:

  • New food safety & security explanations, incorporating Bioterrorism Act provisions
  • Significant additions to the Hatch-Waxman explanations on generic drug approvals
  • New coverage of combination drug, biologics, and device products
  • More detailed explanations on drug, vet drug, and device user fees
  • Updated, comprehensive coverage of over-the-counter drug monographs
  • Additional reporting on food and drug good manufacturing practices

The Food, Drug & Cosmetic Reporter provides everything you need to know about Food and Drug Regulations. Full-text source covering federal and state laws and regulations and court decisions that govern the safety, effectiveness, purity, packaging and labeling of food, drugs and cosmetics.

Order Your Subscription Today »

The Medical Devices Reporter provides access to the full text plus expert analysis of all laws and regulations governing the classification, approval, manufacture, and marketing of all medical diagnostic, and radiological devices.

Order Your Subscription Today »

 

Want to receive these Newsletters via E-mail?

Sign Up / Unsubscribe

CCH Health Care Resources
About the Links in This Newsletter:

To access the CCH® Internet Research Network™ (IRN) full text documents you must be a subscriber to the Medical Devices Reporter or Food, Drug and Cosmetic Law Reporter, IRN product (depending on the link).*

Links within news stories display full text documents including legislation, regulations, court decisions, rulings and government reports.

The first time you click on a link you will be taken to the IRN login page, where you will need to enter your ID and password. Subsequent links will take you directly to the desired document.

Want to Subscribe?

If you aren’t a subscriber call 800-449-9525 or let us contact you about the Medicare and Medicaid Guide.

Signing up for a 7 day free trial will allow you to click on the links within the news stories and see the full text documents.

E-Mail Us

Featured This Week:

Nutritional labeling public docket opened

A public docket to solicit comments, data, and other information helpful to the implementation of §4205 of the Patient Protection and Affordable Care Act of 2010, was established by the FDA. The new PPACA section requires chain restaurants and similar retail food establishments with 20 or more locations doing business under the same name and offering for sale substantially the same menu items to disclose nutrient content information for standard menu items appearing on restaurant menus and menu boards. PPACA also requires vending machine operators that own or operate 20 or more vending machines to disclose nutrient content information for certain articles of food sold from vending machines. The FDA is required to consider standardization of: (1) recipes and methods of preparation, reasonable variation in serving size and formulation of menu items, space on menus and menu boards, inadvertent human error, training of food service workers, variations in ingredients, and other factors as the Secretary determines; and then must (2) specify the format and manner of the nutrient content disclosure requirements. The FDA is tasked to promulgate regulations carrying out the provisions no later than March 23, 2011.

FDA Notice.

Read IRN»   (ip access user) »   (Read Intelliconnect) »

Import, export thresholds on List I chemicals removed

The thresholds for importation, exportation, and domestic distributions of the List I chemicals pseudoephedrine and phenylpropanolamine were removed by the Drug Enforcement Administration (DEA) as part of DEA’s implementation of the Combat Methamphetamine Epidemic Act of 2005. Under the existing regulations the threshold for nonretail distribution, import, export, and international transactions of pseudoephedrine is 1 kilogram and for phenylpropanolamine, 2.5 kilograms. The final rule will require any registrant manufacturing, distributing, importing, or exporting pseudoephedrine or phenylpropanolamine, in any quantity, either as bulk chemicals or in over-the-counter drug products, will be subject to the reporting and recordkeeping requirements.

FDA Order.

Drug product not withdrawn for safety or effectiveness

Actonel® (risendronate sodium) Tablets, 75 milligrams (mg), and Actonel® with Calcium (risendronate sodium and calcium carbonate (copackaged)) Tablets, 35 mg/500 mg, were not withdrawn from sale for reasons of safety or effectiveness in a determination by the FDA. Actonel® is indicated for the treatment of postmenopausal osteoporosis, and Paget’s disease in men and women.

FDA Notice.

Read IRN»   (ip access user) »   (Read Intelliconnect) »

Shell egg regulations go into effect

On July 9, 2010, food safety requirements will become effective for large-scale egg producers having 50,000 or more laying hens – about 80 percent of production — to address the contamination of eggs with the bacterium Salmonella Enteritidis. According to the FDA, as many as 79,000 illnesses and 30 deaths due to consumption of contaminated eggs may be avoided annually with the food safety requirements. The new regulations require egg producers to adopt preventive measures and to use refrigeration during egg storage and transportation. Large-scale egg producers that produce shell eggs for human consumption and do not sell all of their eggs directly to consumers must comply with the refrigeration requirements under the rule; this includes producers whose eggs receive treatments such as pasteurization.

FDA News Release.

CCH is the leading provider of information covering Medicare & Medicaid, Healthcare Compliance, Food, Drug & Cosmetic Law, and Home Health. For more information about our products and services, go to http://health.cch.com/ or call 800-449-9525. This newsletter is copyrighted by CCH and may be redistributed only for non-commercial purposes and only in its entirety, specifically including the CCH headers, this paragraph and the CCH copyright line. No other redistribution or re-purposing, including but not limited to use on a web site, intranet or extranet, is permitted without prior written permission of CCH.

© 2010 CCH. All Rights Reserved.

To opt out of this newsletter or to make changes to your email preferences click here.

contactus@wolterskluwerlb.com